OUP user menu

Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia

M. MANZ, R. MLETZKO, W. JUNG, B. LÜDERITZ
DOI: http://dx.doi.org/ 1123-1128 First published online: 2 August 1992

Abstract

The electrophysiological and haemodynamic effects of lidocaine (100mg) and ajmaline (50 mg) were evaluated while attempting to interrupt sustained ventricular tachycardia. The study was performed as a prospective, non-blinded, randomized investigation in 61 patients. Lidocaine terminated ventricular tachycardia in four of 31 patients, ajmaline in 19 of 30 patients (P<0.001). QRS and RR intervals during ventricular tachycardia were prolonged by ajmaline from 164±28 ms to 214±49ms and from 371±86 ms to 479±137 ms (P<0.001), respectively; lidocaine did not influence these parameters. The duration of the return cycles after termination of ventricular tachycardia did not differ between the two groups. Lidocaine did not change cardiac output during ventricular tachycardia whereas cardiac output increased significantly under ajmaline from 3.5±1.21. min−1 to 5.5±1.91. min−1 (P<0.001). It is concluded that anti-arrhythmic agents such as ajmaline, which slow conduction velocity and prolong refractoriness, are more effective than lidocaine in the medical treatment of haemodynamically stable, sustained ventricular tachycardia.

  • Ventricular tachycardia
  • ajmaline
  • lidocaine
  • sustained ventricular tachycardia

Footnotes

    • Received May 15, 1991.
    • Revision received January 3, 1992.

Sign In

ESC members Follow the 'ESC Member and Congress Delegate Sign In' link below for free online access if your subscription to this journal is via the European Society of Cardiology, either as a member or an ESC Congress delegate. Discover if you are an ESC member here.

Otherwise, if your subscription is via OUP, enter your OUP username and password, or select an alternative sign in option below.

Log in through your institution